22nd Century Group, Inc. (XXII)

22nd Century Group (Nasdaq: XXII) has acquired GVB Biopharma. Read the press release here

22nd Century Group (XXII) Acquires RX Pharmatech Ltd, Greatly Strengthening UK and EU Market Position

View Press Release View All

Jan 23, 2023 • 9:20 AM EST

22nd Century Group (XXII) Announces Filing of U.S. DMF (Drug Master File) for CBD API; New Global Sales, Marketing and Distribution Agreement with Transo-Pharm for Cannabinoid APIs

View Press Release

Jan 18, 2023 • 9:25 AM EST

22nd Century Group (XXII) Announces U.S. Distribution Partnerships with Core-Mark and Eby-Brown

View Press Release

Jan 17, 2023 • 9:00 AM EST

FDA's Proposed Menthol Ban Advances to Final Rule Status, Greatly Benefits 22nd Century (XXII) by Affirming the Need for VLN(R) Menthol King as a Critical Off-Ramp for Adult Menthol Smokers

View Press Release